歡迎進入韦德网站官方入口！
資料下載
首頁 > 資料下載 > matriksbiotek2024年價格表-上海起發

matriksbiotek2024年價格表-上海起發

　發布時間：2024/3/4　點擊量：422

matriksbiotek2024年價(jia) 格表

Matriks Biotek專(zhuan) 門生產(chan) 針對抗體(ti) 藥的ELISA試劑盒，用於(yu) 檢測抗體(ti) 藥的體(ti) 內(nei) 含量或因用於(yu) 產(chan) 生的針對相應抗體(ti) 藥的抗體(ti) 的體(ti) 內(nei) 含量。Matriks Biotek®, SHIKARI®和KLONART®為(wei) Matriks生物技術公司注冊(ce) 的產(chan) 品商標。其產(chan) 品達到ISO 13485 & CE IVD標準。

MatriksBiote抗體(ti) 藥是一類相對新型的生物製劑。檢測抗體(ti) 藥及其抗體(ti) 水平在治療和個(ge) 性化用藥上具有重要意義(yi) 。大量的臨(lin) 床和製藥公司都在致力於(yu) 抗體(ti) 藥物的濃度水平和療效的研究。

特別告知：為(wei) 保證產(chan) 品質量與(yu) 良好性能，所以在購買(mai) 相應產(chan) 品的同時我司會(hui) 收取一定量的運輸費用！！！本次報價(jia) 有效時間為(wei) 2024年1月8日---2024年12月14日。

貨號品名規格價格品牌貨期價格來源
ABA-FD-OREAbatacept (Orencia®) Free drug96T13541.38 matriksbiotek3-4周上海起發
ABA-QLS-OREAbatacept (Orencia®) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發
ABA-QNS-OREAbatacept (Orencia®) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發
ADA-FD-HUMAdalimumab (Humira®) Free drug96T11834.48 matriksbiotek3-4周上海起發
ADA-QLS-HUMAdalimumab (Humira®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發
ADA-QNFT-HUMAdalimumab (Humira®) Antibody screening - Free/Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發
ADA-QNS-HUMAdalimumab (Humira®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
ADA-SPEC-ADAAdalimumab (Humira®) Free drug / Specific96T12289.66 matriksbiotek3-4周上海起發
AFL-FD-EYLAflibercept (Eylea®) Free drug96T12289.66 matriksbiotek3-4周上海起發
AFL-FD-SENS-EYLAflibercept (Eylea®) Free drug96T12289.66 matriksbiotek3-4周上海起發
AFL-QLS-EYLAflibercept (Eylea®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
AFL-QNS-EYLAflibercept (Eylea®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
ATE-FD-TECAtezolizumab (Tecentriq®) Free drug96T12289.66 matriksbiotek3-4周上海起發
ATE-QLS-TECAtezolizumab (Tecentriq®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
BEV-FD-AABevacizumab (Avastin®) Free drug96T11834.48 matriksbiotek3-4周上海起發
CAN-FD-ILACanakinumab (Ilaris®) Free drug96T12289.66 matriksbiotek3-4周上海起發
CAN-QLS-ILACanakinumab (Ilaris®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
CAN-QNS-ILACanakinumab (Ilaris®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
DAR-FD-DARDaratumumab (Darzalex®) Free drug96T12289.66 matriksbiotek3-4周上海起發
DAR-QLS-DARDaratumumab (Darzalex®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
DEN-QNS-PRODenosumab (Prolia®) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發
DUR-FD-IMFDurvalumab (Imfinzi®) Free drug96T12289.66 matriksbiotek3-4周上海起發
DUR-QLS-IMFDurvalumab (Imfinzi®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
ETA-FD-ENBEtanercept (Enbrel®) Free drug96T11834.48 matriksbiotek3-4周上海起發
EVO-FD-REPEvolocumab (Repatha® ) Free drug96T13541.38 matriksbiotek3-4周上海起發
EVO-QLS-REPEvolocumab (Repatha® ) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發
INF-FD-REMIInfliximab (Remicade®) Free drug96T11834.48 matriksbiotek3-4周上海起發
INF-FD-REMSInfliximab (Remsima®) Free drug96T11834.48 matriksbiotek3-4周上海起發
INF-QLS-REMIInfliximab (Remicade®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發
INF-QLS-REMSInfliximab (Remsima®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發
INF-QNFT-REMIInfliximab (Remicade®) Antibody screening - Free/Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發
INF-QNFT-REMSInfliximab (Remsima®) Antibody screening - Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發
INF-QNS-REMIInfliximab (Remicade®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
INF-QNS-REMSInfliximab (Remsima®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
INF-SPEC-INFInfliximab (Remicade®) Free drug / Specific96T12289.66 matriksbiotek3-4周上海起發
NIV-FD-OPDNivolumab (Opdivo®) Free drug96T12289.66 matriksbiotek3-4周上海起發
PAL-FD-SYNPalivizumab (Synagis® ) Free drug96T13541.38 matriksbiotek3-4周上海起發
PAL-QLS-SYNPalivizumab (Synagis® ) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發
PAL-QNS-SYNPalivizumab (Synagis® ) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發
PEM-FD-KEYPembrolizumab (Keytruda®) Free drug96T12289.66 matriksbiotek3-4周上海起發
RAN-FD-LUCRanibizumab (Lucentis®) Free drug96T12289.66 matriksbiotek3-4周上海起發
RIT-FD-RMRituximab (Rituxan®, Mabthera®) Free drug96T12289.66 matriksbiotek3-4周上海起發
RIT-QLS-RMRituximab (Rituxan®, Mabthera®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
RIT-QNS-RMRituximab (Rituxan®, Mabthera®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
SEC-FD-VERSecukinumab (Cosentyx® , Verxant®) Free drug96T12289.66 matriksbiotek3-4周上海起發
SEC-QLS-VERSecukinumab (Cosentyx® , Verxant®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
TOC-QNS-ACTTocilizumab (Actemra®) Antibody screening - Quantitative96T11834.48 matriksbiotek3-4周上海起發
TRA-FD-HHTrastuzumab (Herceptin®, Herclon®) Free drug96T11834.48 matriksbiotek3-4周上海起發
UST-QLS-STEUstekinumab (Stelara®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
VED-FD-ENTVedolizumab (Entyvio®) Free drug96T12289.66 matriksbiotek3-4周上海起發
VED-QLS-ENTVedolizumab (Entyvio®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發


（*此為(wei) 部分產(chan) 品價(jia) 格完整價(jia) 格請下載文件）


關(guan) 鍵詞：matriksbiotek、Matriks Biotek®、KLONART®、SHIKARI®、ELISA試劑盒

文件下載